A group of diseases driven by abnormal cell growth and spread.
Nigeria faces a widening controversy after authorities reveal that a purported Presidential Foreign Intervention Promotion Council (PFIPC) was never legally created, yet received public funds and space. A manhunt is under way for Adeniyi Adeyemi Matthew, who claimed to head the council, with investigations expanding to assess high-level officials’ involvement.
Prime Minister Benjamin Netanyahu has disclosed that doctors found a tiny, early-stage malignant tumor during routine follow-up after 2024 prostate surgery and that targeted radiation therapy has removed it. He has said he delayed publishing the report by two months to avoid fuelling Iranian misinformation during recent clashes. Doctors at Hadassah Medical Center have reported imaging and blood tests showing no remaining disease.
The Princess of Wales has an international mission to champion early childhood development, with a two-day visit to Reggio Emilia, Italy. The trip marks her first major international engagement since cancer remission and will explore the Reggio Emilia approach and global models for supporting young children.
Dalglish has confirmed he is undergoing cancer treatment. He has thanked medical staff for their care and discretion, and asked for privacy as he continues treatment. The news follows reports that he inadvertently posted about his health on social media.
The Department of Health is rolling out AI analysis for chest X-rays across NHS trusts by 2029, backed by funding and pilots. Meanwhile, doctors warn about potential liability issues as AI tools assist with diagnosis, demanding robust governance and accountability.
A Japanese approval for Telomelysin offers a gentler option for esophageal cancer patients ineligible for surgery. Other studies show CAR T-cell therapy remains transformative for certain cancers, while nanotechnology and immunotherapies highlight ongoing progress with meaningful patient impact.
A set of recent reports cover long Covid rehabilitation, a Parkinson’s diagnosis for Bruce Foxton of The Jam, and Lyme disease campaigning by a Scottish MSP. Also covered are ulcerative colitis coupled with PSC in a Birmingham mother and ongoing chronic illness advocacy in media.
The Supreme Court has ruled 7-2 that federal pesticide law bars state failure-to-warn lawsuits over Roundup, overturning a $1.25m jury verdict and imperilling thousands of similar claims against Bayer. The decision follows the EPAs position that glyphosate is unlikely to cause cancer and clears the way for dismissal of many pending suits.
England’s children’s mental health referrals have surpassed 1 million for 2024-25, a rise driven by anxiety and suspected autism. Wait times remain long, with more than 60,000 waiting over two years. The report calls for joined-up services across health, education and social care to meet demand.
A coalition of more than 20 states and the District of Columbia has filed suit against CMS over an interim final rule that tightens Medicaid eligibility by redefining medical frailty and enforcing work or community-engagement requirements for expansion enrollees. The suit argues the rule exceeds the agency’s authority, risks disenfranchising patients with serious illnesses, and forces costly system changes as states prepare for a January 2027 rollout.
The UK–US pharmaceutical deal has led to a BMJ analysis predicting the NHS will divert billions to fund new medicines, risking hundreds of thousands of excess deaths by 2036, with the toll higher if social care funding is included.
Vivani Medical is developing a long-acting semaglutide implant to deliver GLP-1 therapy over months, potentially replacing frequent injections. Novo Nordisk is partnering to evaluate the device, seeking to improve adherence and reduce weight regain.